FDA will allow doctors to use convalescent plasma to treat critical COVID-19 patients
March 26, 2020Business Services COVID-19, China, Chinese Coronavirus, Wuhan Coronavirus, coronavirus
The FDA have announced they will allow doctors to use convalescent plasma, collected from people who recovered from COVID-19, to …
First for Japan with the approval of AstraZeneca’s Lokelma in hyperkalaemia
March 26, 2020Sales and Marketing AstraZeneca, Astra|Zeneca, Japan, Lokelma, hyperkalaemia, pharma
Japan’s Ministry of Health, Labour and Welfare has awarded approval to AstraZeneca’s Lokelma for the treatment of hyerkalaemia, marking the …
Gilead asks FDA to rescind its Orphan Drug status for potential coronavirus treatment following criticism
March 26, 2020Business Services China, Gilead, Wuhan Coronavirus, china coronavirus, coronavirus
Gilead Sciences has submitted a request for the FDA to rescind its offer of Orphan Drug designation for remdesivir in …
Novartis reveals hard-hitting five-year data for its gene therapy Zolgensma in spinal muscular atrophy
March 25, 2020Research and Development Novartis, Zolgensma, gene therapy, pharma, spinal muscular atrophy
Novartis has revealed five-year data on its gene therapy Zolgensma, boasting that the one-time infusion demonstrated “rapid, significant and clinically …
British government protecting high demand medicine for use in COVID-19 patients
March 25, 2020Research and Development COVID-19, china coronavirus, coronavirus
The British government has implemented new restrictions to protect high demand medicines for coronavirus patients. 80 medicines and being banned …
Results released from first clinical trial using Danoprevir to treat COVID-19
March 25, 2020Research and Development COVID, COVID-19, Wuhan, china coronavirus, coronavirus
The first clinical trial using danoprevir (Ganovo) in treating COVID-19 has released its results, showing that it is safe and …
FDA approves supplemental drug application for Pfizer’s EURCRISA in children with eczema
March 25, 2020Research and Development, Sales and Marketing eczema, eczema cream, eczema ointment
Pfizer announced that the FDA has approved its supplemental New Drug Application for EUCRISA ointment in treating 3 month year …
Eyeforpharma Barcelona 2020 is now a free virtual event
March 25, 2020Medical Communications, Research and Development COVID-19, Eyeforpharma Barcelona 2020, coronavirus, events, eyeforpharma, pharma
In light of the rapidly evolving impact of the COVID-19 virus, eyeforpharma has decided to turn eyeforpharma Barcelona 2020 into …
Demand for hydroxychloroquine soars after Trump says it can treat coronavirus
March 25, 2020Research and Development, Sales and Marketing COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus, covid19
President Trump has continually touted the effectiveness of anti-malaria drug Hydroxychloroquine in treating coronavirus which has led to a jump …
AstraZeneca to leverage Silence Therapeutics’ siRNA expertise in $480mn deal
March 25, 2020Research and Development, Sales and Marketing AstraZeneca, Silence Therapeutics, collaboration, pharma
Silence Therapeutics has revealed it has struck a new collaboration with AstraZeneca which will trigger the “acceleration and re-prioritisation of …
Roche shows improved survival rates in new treatment for untreated acute myeloid leukaemia
March 24, 2020Manufacturing and Production Cancer, Roche, acute myeloid leukamia
Roche has announced that its clinical trials for Venclexta/Venclyzto combination with azacitidine have met its primary endpoints of overall survival …
Sustainability and security: How packaging is modernising pharma
March 24, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing counterfeit medicines, falsified medicines, feature, packaging, pharma
In a world living in the shadow of substandard and falsified medicines, climate change and antimicrobial resistance, pharmaceutical packaging will …
Nanovax’s seasonal flu vaccine meets Phase 3 endpoints and matches Sanofi’s Fluzone
March 24, 2020Manufacturing and Production, Research and Development NanoFlu, Nanovax, influenza, pharma
Nanovax has reported positive Phase 3 data for its vaccine NanoFlu, with the candidate meeting its primary endpoints in the …
China approves Takeda’s treatment for ulcerative colitis and Crohn’s disease
March 24, 2020Manufacturing and Production Crohn's, Takeda, Takeda China
China’s National Medical Products Administration (NMPA) has approved Takeda’s Entyvio (vedolizumab) for the treatment of adult patients with ulcerative colitis …
COVID-19: Gilead freezes compassionate access to remdesivir due to “overwhelming demand”, BMS and Lilly delay new study launches
March 24, 2020Manufacturing and Production, Medical Communications, Research and Development Bristol-Myers Squibb, Eli Lilly, Gilead, Roche, cornavirus, pharma
As national governments continue to ramp up measures to contain the ongoing COVID-19 coronavirus outbreak, so too are pharma and …
UK begins lockdown as government announce tough measures to stop the spread of COVID-19
March 24, 2020Manufacturing and Production COVID-19, Chinese Coronavirus, Wuhan Coronavirus, coronavirus, coronavirus pandemic, global pandemic
Last night, British Prime Minister Boris Johnson announced sweeping measures to bring Britain into a near total societal lockdown in …
FDA turns down label expansion for Jardiance as an adjunct to insulin in type 1 diabetes
March 23, 2020Sales and Marketing FDA, diabetes, jardiance, pharma
The FDA has chosen not to approve an expanded indication of 2.5mg Jardiance (empaglifozin) as an adjunct to insulin in …
More young coronavirus patients being hospitalised in Europe and US compared to China
March 23, 2020Sales and Marketing COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus
Dr Anthony Fauci, the Director of the National Institute of Allergy and Infectious Disease in the US, said that people …
ViiV Healthcare scores world-first approval in Canada for monthly HIV regimen Cabenuva
March 23, 2020Sales and Marketing Cabenuva, Canada, HIV, pharma
ViiV Healthcare has secured its first global approval for its once-monthly treatment Cabenuva, it has emerged, to replace current antiretroviral …
AI may help predict patient response to non-small cell lung cancer therapies
March 23, 2020Medical Communications, Sales and Marketing Cancer, Lesions, cancer treatment, tumour treatment
Researchers have used artificial intelligence to train algorithms to predict tumour sensitivity to systemic cancer therapies. Radiologists previously determined if …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
